Sage Therapeutics, Inc. (SAGE)
NASDAQ: SAGE · Real-Time Price · USD
4.850
-0.060 (-1.22%)
Nov 21, 2024, 4:00 PM EST - Market closed
Sage Therapeutics Analyst Ratings
Total Analysts
20
Consensus Rating
Hold
Price Target
$12.83
Upside
+164.54%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| TD Cowen | TD Cowen | Hold Maintains $10 → $9 | Hold | Maintains | $10 → $9 | +85.57% | Nov 21, 2024 |
| RBC Capital | RBC Capital | Sell → Hold Upgrades $4 | Sell → Hold | Upgrades | $4 | -17.53% | Nov 21, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates $14 | Hold | Reiterates | $14 | +188.66% | Nov 20, 2024 |
| Needham | Needham | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Nov 20, 2024 |
| Scotiabank | Scotiabank | Buy Maintains $17 → $14 | Buy | Maintains | $17 → $14 | +188.66% | Oct 30, 2024 |
| Piper Sandler | Piper Sandler | Buy Reiterates $52 → $26 | Buy | Reiterates | $52 → $26 | +436.08% | Oct 30, 2024 |
| Oppenheimer | Oppenheimer | Hold Maintains $9 → $8 | Hold | Maintains | $9 → $8 | +64.95% | Oct 30, 2024 |
| Truist Securities | Truist Securities | Hold Maintains $13 → $8 | Hold | Maintains | $13 → $8 | +64.95% | Oct 30, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Maintains $25 → $14 | Hold | Maintains | $25 → $14 | +188.66% | Oct 30, 2024 |
| Needham | Needham | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Oct 30, 2024 |
| Needham | Needham | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Oct 17, 2024 |
| Raymond James | Raymond James | Hold Initiates n/a | Hold | Initiates | n/a | n/a | Oct 10, 2024 |
| B of A Securities | B of A Securities | Sell Maintains $11 → $6 | Sell | Maintains | $11 → $6 | +23.71% | Oct 9, 2024 |
| Wedbush | Wedbush | Hold Maintains $9 → $8 | Hold | Maintains | $9 → $8 | +64.95% | Oct 9, 2024 |
| Baird | Baird | Hold Maintains $13 → $9 | Hold | Maintains | $13 → $9 | +85.57% | Oct 9, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates $25 | Hold | Reiterates | $25 | +415.46% | Oct 9, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.